Anat Ashkenazi

Anat Ashkenazi

Director of Finance/CFO at ALPHABET INC.

Net worth: 80 M $ as of 30/12/2025

53 year
Consumer Services
Health Technology
Technology Services

Profile

Anat Ashkenazi is on the board of Varian Medical Systems, Inc. and Maravai Lifesciences Holdings, Inc. and Chief Financial Officer & Senior Vice President at Eli Lilly & Co. Ms. Ashkenazi previously was Chief Financial Officer, Controller & Senior VP at Lilly Research Laboratories. Anat Ashkenazi received an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Tel-Aviv University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/02/2025 42,524 ( 0% ) 46 M $ 30/12/2025
24/12/2025 109,145 ( 0% ) 34 M $ 30/12/2025

Anat Ashkenazi active positions

CompaniesPositionStart
ALPHABET INC. Director of Finance/CFO 30/07/2024
Director/Board Member -
Director of Finance/CFO 30/07/2024
All active positions of Anat Ashkenazi

Former positions of Anat Ashkenazi

CompaniesPositionEnd
MARAVAI LIFESCIENCES HOLDINGS, INC. Director/Board Member 30/07/2024
ELI LILLY AND COMPANY Director of Finance/CFO 14/07/2024
VARIAN MEDICAL SYSTEMS, INC. Director/Board Member 14/04/2021
Lilly Diabetes
Director of Finance/CFO -
Director of Finance/CFO -
See the detail of Anat Ashkenazi's experience

Training of Anat Ashkenazi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anat Ashkenazi's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Health Technology

Technology Services

Consumer Services

Consumer Services

Commercial Services

Lilly Diabetes

See company connections
  1. Stock Market
  2. Insiders
  3. Anat Ashkenazi